Please use this identifier to cite or link to this item:
Title: Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
Author: Aglago, Elom K.
Mayén, Ana Lucia
Knaze, Viktoria
Freisling, Heinz
Fedirko, Veronika
Hughes, David J.
Jiao, Li
Eriksen, Anne Kirstine
Tjønneland, Anne
Boutron-Ruault, Marie-Christine
Rothwell, Joseph A.
Severi, Gianluca
Kaaks, Rudolf
Katzke, Verena
Schulze, Matthias B.
Birukov, Anna
Palli, Domenico
Sieri, Sabina
Santucci de Magistris, Maria
Tumino, Rosario
Ricceri, Fulvio
Bueno de Mesquita, H. Bas
Derksen, Jeroen W. G.
Skeie, Guri
Gram, Inger T.
Sandanger, Torkjel Manning
Quirós, J. Ramón
Luján Barroso, Leila
Sánchez, Maria-Jose
Amiano, Pilar
Chirlaque, María Dolores
Gurrea, Aurelio Barricarte
Johansson, Ingegerd
Manjer, Jonas
Perez Cornago, Aurora
Weiderpass, Elisabete
Gunter, Marc J.
Heath, Alicia K.
Schalkwijk, Casper G.
Jenab, Mazda
Keywords: Càncer colorectal
Avaluació de l'estat nutricional
Colorectal cancer
Nutritional status measurement
Issue Date: 8-Sep-2021
Publisher: MDPI AG
Abstract: Dietary advanced glycation end-products (dAGEs) have been hypothesized to be associated with a higher risk of colorectal cancer (CRC) by promoting inflammation, metabolic dysfunction, and oxidative stress in the colonic epithelium. However, evidence from prospective cohort studies is scarce and inconclusive. We evaluated CRC risk associated with the intake of dAGEs in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Dietary intakes of three major dAGEs: Nε-carboxy-methyllysine (CML), Nε-carboxyethyllysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) were estimated in 450,111 participants (median follow-up = 13 years, with 6162 CRC cases) by matching to a detailed published European food composition database. Hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations of dAGEs with CRC were computed using multivariable-adjusted Cox regression models. Inverse CRC risk associations were observed for CML (HR comparing extreme quintiles: HRQ5vs.Q1 = 0.92, 95% CI = 0.85-1.00) and MG-H1 (HRQ5vs.Q1 = 0.92, 95% CI = 0.85-1.00), but not for CEL (HRQ5vs.Q1 = 0.97, 95% CI = 0.89-1.05). The associations did not differ by sex or anatomical location of the tumor. Contrary to the initial hypothesis, our findings suggest an inverse association between dAGEs and CRC risk. More research is required to verify these findings and better differentiate the role of dAGEs from that of endogenously produced AGEs and their precursor compounds in CRC development.
Note: Reproducció del document publicat a:
It is part of: Nutrients, 2021, vol. 13, num. 9, p. 3132
Related resource:
ISSN: 2072-6643
Appears in Collections:Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
nutrients-13-03132.pdf319.93 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons